Harry Yuna, PhD, MBA, is the Global CI Lead of the Hematologic Oncology franchise at Takeda Oncology. His expertise covers broad disease areas including myeloproliferative neoplasms, lymphomas, leukemia, and multiple myeloma etc. As the CI Lead, he is responsible for intelligence...
Read More →